⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ORKA News
Oruka Therapeutics, Inc. Common Stock
Form 8-K
sec.gov
ORKA
Oruka Therapeutics Announces Positive Week 16 Results for ORKA-001 from the Ongoing EVERLAST-B Trial in Moderate-to-Severe Psoriasis
globenewswire.com
ORKA
Oruka Therapeutics to Host Conference Call to Report Week 16 Data for ORKA-001 from the Ongoing EVERLAST-B Trial on October 26, 2026
globenewswire.com
ORKA
Oruka Therapeutics Announces Positive Week 28 Data for ORKA-001 from the Ongoing EVERLAST-A Trial Showing Deepening of Responses Without Additional Dosing
globenewswire.com
ORKA
Oruka Therapeutics to Attend the 2026 Morgan Stanley Global Healthcare Conference
globenewswire.com
ORKA
Form 8-K
sec.gov
ORKA
Oruka Therapeutics Appoints Todd Edwards as Chief Commercial Officer
globenewswire.com
ORKA
Form 8-K
sec.gov
ORKA
Form 8-K
sec.gov
ORKA
Form 8-K
sec.gov
ORKA